HK1034264A1 - Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them - Google Patents

Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them

Info

Publication number
HK1034264A1
HK1034264A1 HK01104753A HK01104753A HK1034264A1 HK 1034264 A1 HK1034264 A1 HK 1034264A1 HK 01104753 A HK01104753 A HK 01104753A HK 01104753 A HK01104753 A HK 01104753A HK 1034264 A1 HK1034264 A1 HK 1034264A1
Authority
HK
Hong Kong
Prior art keywords
monoclonal antibodies
compositions containing
malignant tumors
active immunotherapy
idiotype monoclonal
Prior art date
Application number
HK01104753A
Other languages
English (en)
Inventor
Ana Maria Vasquez Lopez
Rolando Perez Rodriguez
Eladio Iglesias Sierra
Alexis Perez Gonzalez
Gumersinda Bombino Lopez
Irene Beausoleil Delgado
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Publication of HK1034264A1 publication Critical patent/HK1034264A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK01104753A 1997-10-21 2001-07-10 Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them HK1034264A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1997119A CU22702A1 (es) 1997-10-21 1997-10-21 Anticuerpos monoclonales anti - idiotipo, su uso en la inmunoterapia activa de tumores malignos, hibridoma que los produce y composiciones que los contienen
PCT/CU1998/000007 WO1999020656A1 (es) 1997-10-21 1998-10-21 Anticuerpos monoclonales anti-idiotipos, su uso en la inmunoterapia activa de tumores malignos, y composiciones que los contienen

Publications (1)

Publication Number Publication Date
HK1034264A1 true HK1034264A1 (en) 2001-10-19

Family

ID=5459399

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104753A HK1034264A1 (en) 1997-10-21 2001-07-10 Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them

Country Status (20)

Country Link
EP (1) EP1027375B1 (es)
JP (1) JP4304287B2 (es)
KR (1) KR100567209B1 (es)
CN (1) CN1210309C (es)
AR (1) AR017369A1 (es)
AT (1) ATE341564T1 (es)
AU (1) AU1019999A (es)
BR (1) BR9812974A (es)
CA (1) CA2308142C (es)
CO (1) CO5060487A1 (es)
CU (1) CU22702A1 (es)
CY (1) CY1105844T1 (es)
DE (1) DE69836096T2 (es)
DK (1) DK1027375T3 (es)
EA (1) EA003366B1 (es)
ES (1) ES2274584T3 (es)
HK (1) HK1034264A1 (es)
PT (1) PT1027375E (es)
SI (1) SI1027375T1 (es)
WO (1) WO1999020656A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
WO2011051466A1 (en) * 2009-11-02 2011-05-05 Novartis Ag Anti-idiotypic fibronectin-based binding molecules and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010221A1 (en) * 1991-11-13 1993-05-27 The Regents Of The University Of California Chimeric murine/human anti-idiotype monoclonal antibodies
US5653977A (en) * 1993-09-09 1997-08-05 Uab Research Foundation Anti-idiotypic antibody that mimics the GD2 antigen
ES2166770T3 (es) * 1993-12-09 2002-05-01 Centro Inmunologia Molecular Anticuerpos monoclonales contra gangliosidos y sus utilizaciones en la inmunoterapia activa especifica de tumores malignos.
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
CU22585A1 (es) * 1995-11-17 1999-11-03 Centro Inmunologia Molecular Anticuerpos monoclonales antiidiótipos (ab2) de tipo igg con alta conectividad idiotípica y composiciones farmacéuticas que los contienen. su uso como inmunoreguladores de la respuesta inmune.
US5792455A (en) * 1996-03-21 1998-08-11 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody vaccines

Also Published As

Publication number Publication date
EA003366B1 (ru) 2003-04-24
CO5060487A1 (es) 2001-07-30
CN1279692A (zh) 2001-01-10
EP1027375B1 (en) 2006-10-04
ES2274584T3 (es) 2007-05-16
DE69836096D1 (de) 2006-11-16
PT1027375E (pt) 2007-01-31
CU22702A1 (es) 2001-07-31
CA2308142A1 (en) 1999-04-29
KR100567209B1 (ko) 2006-04-03
KR20010031283A (ko) 2001-04-16
DE69836096T2 (de) 2007-05-16
CY1105844T1 (el) 2011-02-02
ATE341564T1 (de) 2006-10-15
CA2308142C (en) 2005-06-14
BR9812974A (pt) 2000-08-08
AU1019999A (en) 1999-05-10
JP2001520034A (ja) 2001-10-30
DK1027375T3 (da) 2007-02-05
WO1999020656A1 (es) 1999-04-29
CN1210309C (zh) 2005-07-13
JP4304287B2 (ja) 2009-07-29
SI1027375T1 (sl) 2007-02-28
EA200000442A1 (ru) 2000-10-30
EP1027375A1 (en) 2000-08-16
AR017369A1 (es) 2001-09-05

Similar Documents

Publication Publication Date Title
HUP0002095A3 (en) Compounds for immunotherapy of prostate cancer and methods for their use
IL131539A0 (en) Compounds for immunodiagnosis of prostate cancer and methods for their use
AU2472400A (en) CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
IL136335A0 (en) Monoclonal human natural antibodies
AU5414996A (en) Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
IL125608A0 (en) Tumor associated antigen peptides and use of same as anti-tumor vaccines
HUP9901874A3 (en) Human antibodies binding human tnfalfa, pharmaceutical compositions containing thereof and use thereof
ZA957634B (en) Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
IL145800A0 (en) Immunotheraphy of cancer through expression of truncated tumor of tumor-associated antigen
HUP0002831A3 (en) Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
AU7676300A (en) Human anti-adipocyte monoclonal antibodies and their use
AU9053991A (en) Conjugates of anti-idiotype antibodies and carriers and their use in epitope-directed immunization
NZ501742A (en) Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
IL116228A0 (en) Monoclonal antibody fragments and pharmaceutical compositions containing them
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
HK1034264A1 (en) Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them
AU9689398A (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
ZA958229B (en) Composition containing tumor rejection antigen prcursors or tumor rejection antigens and an adjuvant and/or growth factor
AU9018598A (en) Prognostic compositions for prostate cancer and methods of use thereof
AU2003204129A1 (en) Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them
AU3544599A (en) Use of radiolabeled monoclonal igm in therapy for cancer and autoimmune disease
EP1136555A4 (en) TUMORANT PROTEIN ART-1 AND TUMORANT PEPTIDES THEREOF
AU2003204088A1 (en) Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
ZA941645B (en) Antibodies specifically reactive against human prostate specific antigen.
AU7832700A (en) Ovarian tumor antigen and methods of use therefor

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20181020